Skip to main content

Table 2 Associations between various DXA-based fat depots and incident atrial fibrillation

From: Imaging-based body fat depots and new-onset atrial fibrillation in general population: a prospective cohort study

DXA-based (N = 3468)

Hazard ratio (95% confidence interval)

Model 1

Model 2

Model 3a

Model 4b

Total fat mass

1.28 (1.15–1.42)

1.22 (1.09–1.36)

1.17 (1.04–1.32)

–

 Fat mass percentage

1.22 (1.07–1.41)

1.19 (1.03–1.37)

–

–

Android fat mass

1.20 (1.09-1.32)

1.14 (1.03–1.27)

1.06 (0.94–1.19)

0.78 (0.60–1.02)

 Android fat percentage

1.09 (0.99–1.21)

1.06 (0.95–1.18)

1.04 (0.93–1.16)

–

Gynoid fat mass

1.31 (1.18–1.46)

1.26 (1.13–1.41)

1.21 (1.08–1.37)

1.36 (0.96–1.93)

 Gynoid fat percentage

1.28 (1.09–1.49)

1.25 (1.07–1.47)

1.28 (1.09–1.50)

–

Android-to-gynoid

fat ratio

0.93 (0.81–1.06)

0.85 (0.74–0.98)

0.84 (0.72–0.97)

0.82 (0.70–0.95)

  1. Values are shown as hazard ratios and 95% confidence interval per 1 standard deviation increase of corresponding fat depots
  2. Abbreviations DXA Dual-energy X-ray absorptiometry
  3. Model 1 was adjusted for sex and age
  4. Model 2 was additionally adjusted for high-density lipoprotein cholesterol, total cholesterol, smoking, total alcohol intake, lipid-lowering medication and cardiac medication and history of hypertension, left ventricular hypertrophy, diabetes mellitus, heart failure, and coronary heart disease
  5. aModel 3: Model 2 + total lean mass
  6. bModel 4: Model 2 + total fat mass